Barclays 27th Annual Global Healthcare Conference Call March 12, 2025 2:00 PM ETCompany ParticipantsBrian Evanko - Chief ...

Mía had dystrophic epidermolysis bullosa, better known as butterfly skin due to the extreme fragility of this tissue in ...

The Swiss pharma group said this morning that the separation "is in the best interest of shareholders" and will create the number one generics company in Europe and a leader in biosimilars ...

The reaction from within the political sphere was immediate, with the White House and President Biden immediately releasing a statement welcoming ... Act’, for example, had provided a guarantee ...

The inquiry is the latest effort by the European Commission and European countries to scrutinize potential antitrust behavior ...

An appeals court has upheld a District Court’s denial of a preliminary injunction for Amgen’s (AMGN) Eylea biosimilar, which UBS analyst Trung ...

TORONTO--(BUSINESS WIRE)--Celltrion, Inc., a leading global biopharmaceutical company, announced today that its infliximab biosimilar will be marketed in Canada under the new brand name Remdantry ...

Conditional reasoning may be phrased in various ways, but it can be essentially reduced to if-then statements. For example: "If you are a lawyer, then you must have passed the bar exam." ...

While the two Democratic Commissioners issued a concurring statement asserting the transaction is an example of a “problematic playbook… [of] a private equity” company, the complaint and the ...

Celltrion and Formycon with Fresenius Kabi launched their respective ustekinumab biosimilars (Steqeyma and Otulfi), joining 4 ...

The denosumab biosimilar market is poised for disruption with 3 FDA-approved biosimilars, at least 5 awaiting approval, and ...